Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations.

Allergy and asthma proceedings·2026
Same author

Corrigendum to 'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology' [Annals of Allergy, Asthma & Immunology 133/3 (2024) 286-94].

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024
Same author

Impaired B-cell function in <i>ERCC2</i> deficiency.

Frontiers in immunology·2024
Same author

A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024
Same author

Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma.

Respiratory medicine·2024
Same author

Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.

Lancet (London, England)·2023
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling
10:29

Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling

Published on: April 3, 2026

Newborn screening for T-cell deficiency.

Nicole M Chase1, James W Verbsky, John M Routes

  • 1Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Current Opinion in Allergy and Clinical Immunology
|September 25, 2010
PubMed
Summary
This summary is machine-generated.

Newborn screening for T-cell deficiency is now available, identifying infants with severe combined immunodeficiency (SCID). Early detection through newborn blood screening (NBS) enables timely treatment, improving outcomes for affected infants.

More Related Videos

Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR
14:14

Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR

Published on: December 6, 2014

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

Related Experiment Videos

Last Updated: Jun 8, 2026

Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling
10:29

Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling

Published on: April 3, 2026

Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR
14:14

Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR

Published on: December 6, 2014

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Newborn screening (NBS) has advanced from detecting metabolic disorders to identifying genetic conditions like severe combined immunodeficiency (SCID).
  • T-cell deficiency screening via NBS is a critical development in early diagnosis of primary immunodeficiencies.

Purpose of the Study:

  • To review the history, methods, results, challenges, and future of newborn screening for T-cell deficiency.
  • To highlight the favorable outcomes of T-cell deficiency screening in Wisconsin.

Main Methods:

  • Review of published data on T-cell deficiency screening programs.
  • Discussion of evolving DNA-based technologies for NBS.
  • Analysis of diagnostic and follow-up protocols for infants identified with T-cell lymphopenia.

Main Results:

  • Newborn blood screening (NBS) successfully identified infants with SCID, enabling timely hematopoietic stem cell transplant (HSCT).
  • The utility of NBS for T-cell deficiency relies on rigorous protocols, seamless follow-up, and specialized training for clinical immunologists.
  • DNA-based NBS assays are being developed for other serious infant diseases.

Conclusions:

  • Newborn screening for T-cell deficiency marks a significant advancement in detecting primary immunodeficiencies in infants.
  • Early identification and intervention are crucial for improving the prognosis of infants with SCID.